ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
ImCheck raises Series B funds to develop gamma delta therapies
December 09, 2019French biotech firm ImCheck Therapeutics has raised $53m (€48m) in a Series B funding round to develop its gamma delta (γδ) T-cell-based antibodies to treat cancer and autoimmune disorders. -
Gilead’s Kite bags option to buy gamma delta startup Gadeta
July 23, 2018Gilead’s Kite Pharma has snagged an option to buy gamma delta T-cell receptor (TCR) startup Gadeta. The deal sees Kite take a stake in Gadeta and commit to milestones tied to the progress of oncology candidates.
Pharma Sources Insight January 2025
